Chronic ethanol ingestion increases superoxide production and NADPH oxidase expression in the lung

American Journal of Respiratory Cell and Molecular Biology

Volumn 34, Issue 3, 2006, Pages 314-319

  Polikandriotis, John A ^a   Rupnow, Heidi L ^b   Elms, Shawn C ^b   Clempus, Roza E ^b   Campbell, Duncan J ^b   Sutliff, Roy L ^b   Brown, Lou Ann S ^b   Guidot, David M ^b   Hart, C Michael ^b  

^a EMORY UNIVERSITY   (United States)

^b NONE

Author keywords

ARDS; Chronic ethanol ingestion; Lung; NADPH oxidase; Superoxide

Indexed keywords

ALCOHOL; ANGIOTENSIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; DEXTRIN; DIPEPTIDYL CARBOXYPEPTIDASE; GLUTATHIONE DISULFIDE; LISINOPRIL; MALTOSE; PROTEIN P22; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; RENIN; RNA; SUPEROXIDE;

ADULT RESPIRATORY DISTRESS SYNDROME; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOPRECIPITATION; LUNG; LUNG LAVAGE; MALE; NONHUMAN; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WESTERN BLOTTING;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINOGEN; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; ETHANOL; GLUTATHIONE DISULFIDE; LISINOPRIL; LUNG; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NADPH OXIDASE; OXIDATIVE STRESS; PEPTIDYL-DIPEPTIDASE A; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; SUPEROXIDES;

ANIMALIA;

EID: 33644614416     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2005-0320OC     Document Type: Article

References (38)

1. Ware LB, Matthay MA. The Acute Respiratory Distress Syndrome. N Engl J Med 2000;18:1334-1349.
2. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163:1376-1383.
3. Moss M, Parsons PE, Steinberg KP, Hudson LD, Guidot DM, Burnham EL, Eaton S, Catsonis GA. Chronic alcohol abuse is associated with an increased incidence of ARDS and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med 2003;31:869-877.
4. Brown LAS, Harris FL, Bechara R, Guidot DM. Effect of chronic EtOH ingestion on alveolar type II cell: glutathione and inflammatory mediator-induced apoptosis. Alc Clin Exp Res 2001;25:1078-1085.
5. Guidot DM, Modelska K, Lois M, Jain L, Moss IM, Pittet JF, Brown LAS. Ethanol ingestion via GSH depletion impairs alveolar epithelial barrier function in rats. Am J Physiol 2000;279:L127-L135.
6. Guidot DM, Brown LAS. Mitochondrial glutathione replacement restores surfactant synthesis and secretion in alveolar epithelial cells in ethanol-fed rats. Alc Clin Exp Res 2000;24:1070-1076.
7. Holguin F, Moss IM, Brown LAS, Guidot DM. Chronic ethanol ingestion impairs alveolar type II cell glutathione homeostasis and function and predisposes to endotoxin-mediated acute edamatous lung injury in rats. J Clin Invest 1998;101:761-768.
8. Moss M, Guidot DM, Wong-Lambertina M, Ten Hoor T, Perez RL, Brown LAS. The effects of chronic alcohol abuse on pulmonary GSH homeostasis. Am J Respir Crit Care Med 2000;161:414-419.
9. Puddey IB, Beilin LJ, Vandongen R. Regular alcohol use raises blood pressure in treated hypertensive subjects. Lancet 1987;8534:647-651.
10. Linkola J, Fyhrquist F, Ylikahri R. Renin aldosterone and cortisol during ethanol intoxication and hangover. Acta Physiol Scand 1979;106:75-82.
11. Wright JW, Morseth SL, Abhold RH, Harding JW. Elevations in plasma angiotensin II with prolonged ethanol treatment in rats. Pharmacol Biochem Behav 1986;24:813-818.
12. Morgan L, Pipkin FB, Kalheker N. Angiotensinogen: molecular biology, biochemistry and physiology. Int J Biochem Cell Biol 1996;11:1211-1222.
13. Xaio F, Puddefoot JR, Vinson GP. The expression of renin and the formation of angiotensin II in bovine aortic endothelial cells. J Endocrinol 2000;164:207-214.
14. Igic R, Behnia R. Properties and distribution of angiotensin I converting enzyme. Curr Pharm Des 2003;9:697-706.
15. Cziraki A, Horvath IG, Papp L. Endothelial function studies in pulmonary vascular disease: determination of ACE activity in humans. Int J Mol Med 2002;3:317-325.
16. Inagami T. Molecular biology and signaling of angiotensin receptors. J Am Soc Nephrol 1999;10:S2-S7.
17. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, Taylor WR, Griendling KK. Role of NADH/NADPH oxidase derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998;32:488-495.
18. Griendling KK, Minieri CA, Ollernshaw JD, Alexader RW. Angiotensin II stimulates NADH and NADPH oxidase in cultured vascular smooth muscle cells. Circ Res 1994;74:1141.
19. DeKeulenaer GW, Alexander RW, Ushio-Fukai M, Ishizaka N, Griendling KK. TNFalpha actives a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 1998;329:653-657.
20. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, et al. Effects of angiotensin II infusion on the expression and function of NADPH oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002;90:e58-e65.
21. Lang D, Mosfer SI, Shakesby A, Donaldson F, Lewis MJ. Coronary microvascular endothelial cell redox state in L ventricular hypertrophy: the role of Ang II. Circ Res 2000;86:463-469.
22. Griendling KK, Sorescu D, Ushio-Fukai M. NADPH oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494-501.
23. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000;20:2175-2183.
24. Lassegue B, Clempus RE. Vascular NADPH oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003;285:R277-R297.
25. Babior BM. NADPH oxidase: an update. Blood 1999;93:1464-1476.
26. Bechara RI, Palaez A, Palacio A, Joshi PC, Hart CM, Brown LAS, Raynor R, Guidot DM. Angiotensin II mediates glutathione depletion, transforming growth factor-beta1 expression, and epithelial barrier dysfunction in the alcoholic rat lung. Am J Physiol Lung Cell Mol Physiol 2005;289:L363-L370.
27. Lieber CS, DeCarli LM. The feeding of alcohol in liquid diets: two decades of applications and 1982 update. Alc Clin Exp Res 1982;6:523-531.
28. Miller FJ, Gutterman DD, Rios CD, Heisted DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998;82:1298-1305.
29. Campbell DJ, Lawrence AC, Kladis A, Duncan A-M. Strategies for measurement of angiotensin and bradykinin peptides and their metabolites in central nervous system and other tissues. In: Smith AI, editor. Methods in neurosciences, volume 23: peptidases and neuropeptide processing. Orlando: Academic Press; 1995. pp. 328-343.
30. Martni J, White JM. Fluorimetric determination of oxidized and reduced glutathione in cells and tissues by high performance liquid chromatography following derivatization with dansyl chloride. J Chromatogr 1991;568:221-225.
31. Wenz M, Steinau R, Gerlach H, Lange M, Kaczmarczyk G. Inhaled nitric oxide does not change transpulmonary AngII formation in patients with ARDS. Chest 1997;112:478-483.
32. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ. ACE insertion/deletion polymorphism is associated with susceptibility and outcome in ARDS. Am J Respir Crit Care Med 2002;166:646-650.
33. Kang N, Walther T, Tian XL, Bohlender J, Fukamizu A, Ganten D, Bader M. Reduced hypertension-induced end-organ damage in mice lacking cardiac and renal angiotensinogen synthesis. J Mol Med 2002;80:359-366.
34. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 2000;9:21-27.
35. Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 2002;4:899-914.
36. Gao XP, Standiford TJ, Rahman A, Newstead M, Holland SM, Dinauer MC, Liu QH, Malik AB. Role of NADPH oxidase in the mechanism of lung neutrophil sequestration and microvessel injury induced by gram-negative sepsis: studies in p47 -/- and gp91 -/- mice. J Immunol 2002;168:3974-3982.
37. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA. Role of NADPH oxidase in the vasculature hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 2001;88:947-953.
38. Rueckschloss U, Quinn MT, Holtz J, Moraweitz H. Dose-dependent regulation of NADPH oxidase expression by angiotensin II in human endothelial cells. Arterioscler Thromb Vasc Biol 2002;22:1845-1851.